Class Members Eligible for Skelaxin (Metaxalone) End Payor Antitrust Litigation Settlement:
All persons or entities in the United States and its territories who purchased and/or paid for some or all of the purchase price for Skelaxin and/or its AB-rated generic equivalents in Arizona, Arkansas, California, the District of Columbia, Florida, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Mexico, New York, North Carolina, North Dakota, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Vermont, Virginia, West Virginia, or Wisconsin (collectively, the “Class States”), in any form, for consumption by themselves, their families, or their members, employees, insureds, participants, or beneficiaries, other than for resale, during the Class Period. For purposes of the Class definition, persons or entities “purchased” Skelaxin or its generic equivalent if they paid or reimbursed some or all of the purchase price. The following are excluded from the Class:
- Defendants and their officers, directors, management, employees, subsidiaries, or affiliates, and all federal, state and municipal government entities, except for government funded employee benefit plans;
- Fully insured health plans (i.e., plans that purchased insurance from another thirdparty payor (“TPP”) covering I00% of the Plan’s reimbursement obligations to its members);
- “Flat co-payor” consumers whose plans at the time of purchase would have required them to pay the same fixed dollar co-payment amount for Skelaxin as for generic metaxalone. (The exclusion in this subparagraph “c” shall apply solely to the extent of purchases by such consumers with a fixed dollar co-payment and not with respect to any other purchases by such consumers); and
- End-payors who paid for Skelaxin or generic metaxalone that was acquired solely through a prison or federal, state or municipal facility. (The exclusion in this subparagraph “d” shall apply solely to the extent of the just specified payments and not with respect to any other payments for Skelaxin or generic metaxalone by such end-payors).
Skelaxin End Payor Settlement Case History:
Several parties (“Plaintiffs” or “Class Representatives”) filed multiple lawsuits alleging that King Pharmaceuticals, Inc. (“King”) and Mutual (collectively, “Defendants”) engaged in a scheme to unlawfully exclude from the market AB-rated generic equivalents of metaxalone, a prescription muscle relaxant, which has been sold under the brand name Skelaxin since 1962.
Plaintiffs’ Actions were consolidated with related cases filed by other plaintiffs under the caption In Re: Skelaxin (Metaxalone) Antitrust Litigation, MDL No. 2343, before the United States District Court for the Eastern District of Tennessee (the “Court”), and Plaintiffs’ Consolidated Amended Class Action Complaint, filed November 2,2012 (the “Complaint”) asserts claims on behalf of a putative class of persons or entities who purchased Skelaxin tablets indirectly and not for resale at any time during the period November 4, 2005 through the date of Preliminary Approval (the “Class Period”).
Mutual denies each and every one of Plaintiffs’ allegations, has not conceded or admitted any liability, and has asserted a number of defenses to Plaintiffs’ claims;
Our Class Action Settlement Services:
CAC Recovery navigates the complex intricacies of the Skelaxin End Payor Antitrust Litigation Settlement claims filing process to help businesses maximize their settlement recoveries.
Our class action settlement services include:
- Identifying class action claims where businesses may be eligible to file
- Filing the class action claim with supporting documentation
- Interacting with the class action Claims Administrator
- Providing updates on class action claim settlements status
- Resolving Claims Administrator questions on claims
- Reviewing the recovery to assure the correct compensation claims amount has been received
Our Guarantee: We Get Paid When You Recover – No hidden charges or up-front fees. We provide our class action settlements services based on a contingency fee.
Getting Started is easy! If you represent a business we’ll first have you fill out our ‘Get Started‘ form and a CAC representative will contact you within 24 hours to review your eligibility and walk you through the claims process.